Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pidnarulex
Large B-Cell Lymphoma
National Cancer Institute (NCI)P1/2CC (47)
Polyethyleneglycol-7-Ethyl-10-Hydroxycamptothecin Dfp-13318
Medulloblastoma
National Cancer Institute (NCI)P1/2CC (47)
Selinexor
IDH-Wildtype Glioblastoma
National Cancer Institute (NCI)P1/2CC (47)
Sirolimus
Skin Basal Cell Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
SX682
Adenoid Cystic Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
SX682
Salivary Gland Cancer
National Cancer Institute (NCI)P1/2CC (47)
Tarlatamab
Small Cell Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
Tazemetostat Hydrobromide
Cutaneous Melanoma
National Cancer Institute (NCI)P1/2CC (47)
Tolinapant
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
Tolinapant
Ovarian Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
Tolinapant
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
Tolinapant
Fallopian Tube Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P1/2CC (47)
Tolinapant
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P1/2CC (47)
Tolinapant
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P1/2CC (47)
Tolinapant
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)P1/2CC (47)
Tolinapant
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
Trastuzumab Deruxtecan
Lung Cancer
National Cancer Institute (NCI)P1/2CC (47)
Trastuzumab Deruxtecan
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P1/2CC (47)
Adavosertib
Nonpapillary Renal Cell Carcinoma
National Cancer Institute (NCI)P2CC (46)
Adavosertib
Colorectal Carcinoma
National Cancer Institute (NCI)P2CC (46)
Adavosertib
Glioma
National Cancer Institute (NCI)P2CC (46)
Copanlisib
Carcinoma Of Esophagus
National Cancer Institute (NCI)P2CC (46)
Copanlisib
Cancer
National Cancer Institute (NCI)P2CC (46)
Copanlisib
Prostate Carcinoma
National Cancer Institute (NCI)P2CC (46)
Fexagratinib
Plasma Cell Myeloma
National Cancer Institute (NCI)P2CC (46)
Showing 2526 to 2550 of 3,272 assets
PreviousPage 102 of 131Next